Are Sodium-Glucose Cotransporter-2 Inhibitors Fantastic for Coronary Plaque Stabilization?
-
Published:2024-07
Issue:
Volume:222
Page:95
-
ISSN:0002-9149
-
Container-title:The American Journal of Cardiology
-
language:en
-
Short-container-title:The American Journal of Cardiology
Author:
Minami YoshiyasuORCID,
Iwaya Toshiyuki
Reference4 articles.
1. Sodium-glucose cotransporter-2 inhibitors stabilize coronary plaques in acute coronary syndrome with diabetes mellitus;Kurozumi;Am J Cardiol,2024
2. Minami Y, Ako J, Tsujita K, Yokoi H, Ikari Y, Morino Y, Kobayashi Y, Kozuma K. Drug intervention as an emerging concept for secondary prevention in patients with coronary disease [published online April 8, 2024]. Cardiovasc Interv Ther doi: 10.1007/s12928-024-00994-7.
3. Effect of evolocumab on coronary plaque phenotype and burden in statin-treated patients following myocardial infarction;Nicholls;JACC Cardiovasc Imaging,2022
4. Comparison of intensive versus moderate lipid-lowering therapy on fibrous cap and atheroma volume of coronary lipid-rich plaque using serial optical coherence tomography and intravascular ultrasound imaging;Hou;Am J Cardiol,2016